Effective management of breast cancer depends on early diagnosis and proper monitoring
of patients' response to therapy. However, these goals are difficult to achieve because of the …

Breast cancer is a highly prevalent disease, accounting for 29% of invasive cancers in
women. Survival from this disease depends on the stage at diagnosis, with patients who are …

Purpose Novel noninvasive biomarkers with high sensitivity and specificity for the diagnosis
of breast cancer (BC) are urgently needed in clinics. The aim of this study was to explore …

MicroRNAs are dysregulated in breast cancer. Heterogeneous Nuclear Ribonucleoprotein
A2/B1 (HNRNPA2/B1) is a reader of the N (6)-methyladenosine (m6A) mark in primary …

Breast cancer is the second most common cause of deaths reported in women worldwide,
and therefore there is a need to identify breast cancer patients at an early stage as timely …

Breast cancer is a complex and heterogeneous disease. Signaling by estrogen receptor
(ER), progesterone receptor (PR), and/or human EGF-like receptor 2 (HER2) is a main driver …

The expression of microRNAs (miRNAs) in a tissue-and development-specific manner has
indicated that they play an essential role in the maintenance of biological homeostasis. In …

OBJECTIVE: Circulating microRNAs have been recognized as promising biomarkers for
various diseases. The present study aimed to explore the potential roles of circulating miR …

Background MicroRNAs (miRNAs) are important regulators of cellular function and have
been associated with both aging and cancer, but the impact of chemotherapy on age-related …

It is believed that microRNAs have potential as circulating biomarkers of disease; however,
successful clinical implementation remains a challenge. This chapter highlights broad …